Skip to main content

Advertisement

SpringerLink
Log in

A Comparative Analysis of p63 Expression in Giant Cell Tumour (GCT), Central Giant Cell Granuloma (CGCG) and Peripheral Giant Cell Granuloma (PGCG)

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Giant cell tumour (GCT) is locally aggressive benign neoplasm of long bones whereas giant cell granulomas; central giant cell granuloma (CGCG) and peripheral giant cell granuloma (PGCG); are tumour-like conditions of the oral cavity. This study aimed to evaluate and compare the immunohistochemical expression of p63 in GCT, CGCG, PGCG and determine whether p63 can be used as a diagnostic, prognostic and differential biomarker between these entities. Histopathologically diagnosed 10 cases of GCT, 20 cases of CGCG and 20 cases of PGCG were subjected to p63 immunohistochemical staining. The percentage of p63-positive cells was semi-quantitatively assessed on the whole section. Intergroup comparison was done using Kruskal–Wallis test and one-way ANOVA. The value p < 0.05 was considered to be statistically significant and value p < 0.01 was considered to be statistically highly significant. p63 immunoexpression was seen in 100% (10/10) cases of GCT whereas CGCG and PGCG revealed the complete absence of p63 immunopositivity. These results showed a highly significant difference in p63 expression between GCT, CGCG and PGCG (p < 0.01). No difference was noted between CGCG and PGCG. GCT is a distinct entity when compared with CGCG and PGCG. Even aggressive CGCG also did not show p63 immunopositivity, so it is not a prognostic marker. Also, p63 cannot differentiate between CGCG and PGCG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mavrogenis AF, Igoumenou VG, Megaloikonomos PD, Panagopoulos GN, Papagelopoulos PJ, Soucacos PN. Giant cell tumor of bone revisited. SICOT J. 2017;3:54.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Reid R, Banerjee SS, Sciot R. Giant cell tumour. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization classification of tumours, pathology and genetics of soft tissue and bone. Lyon: IARC; 2002. p. 309–13.

    Google Scholar 

  3. Sidhu MS, Parkash H, Sidhu SS. Central giant cell granuloma of jaws—review of 19 cases. Br J Oral Maxillofac Surg. 1995;33(1):43–6.

    Article  CAS  PubMed  Google Scholar 

  4. Waldron CA, Shafer WG. The central giant cell reparative granuloma of the jaws. An analysis of 38 cases. Am J Clin Pathol. 1966;45(4):437–47.

    Article  CAS  PubMed  Google Scholar 

  5. Chandna P, Srivastava N, Bansal V, Wadhwan V, Dubey P. Peripheral and central giant cell lesions in children: institutional experience at Subharti Dental College and Hospital. Indian J Med Paediatr Oncol. 2017;38(4):440–6.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Motamedi MH, Eshghyar N, Jafari SM, Lassemi E, Navi F, Abbas FM, Khalifeh S, Eshkevari PS. Peripheral and central giant cell granulomas of the jaws: a demographic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2007;103(6):39–43.

    Article  Google Scholar 

  7. Auclair PL, Cuenin P, Kratochvil FJ. A clinical and histomorphologic comparison of the giant cell granuloma and the giant cell tumour. Oral Surg Oral Med Oral Pathol Oral Radiol. 1988;66:197–208.

    Article  CAS  Google Scholar 

  8. Yang A, Kaghad M, Wang Y, Gillet E, Fleming M, Dotsch V, Andrews N, Caput D, McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing and dominant-negative activities. Mol Cell. 1998;2:305–16.

    Article  CAS  PubMed  Google Scholar 

  9. Hammas N, Laila O, Youssef ALM, Hind BF, Harmouch T, Sham T. Can p63 serve as a biomarker for giant cell tumour of bone? A Moroccan experience. Diagn Pathol. 2012;7(1):130.

    PubMed  Google Scholar 

  10. .Dickson BC, Shu-Qui L, Wunder JS, Ferguson PC, Eslami B, Werier JA, Turcotte RE, Kandel RA (2008) Giant cell tumour of bone express p63. Mod Pathol 21:369–75

  11. Lee CH, Inigo E, Kristin CJ, Subbaya S, Shirley XZ, Sushma V, Montgomery KD, Nielsen TO, van de Rijn M, West RB. Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumour of the bone. Mod Pathol. 2008;21:531–9.

    Article  CAS  Google Scholar 

  12. De la Roza G. p63 expression in giant cell-containing lesions of bone and soft tissue. Arch Pathol Lab Med. 2011;135:776–9.

    PubMed  Google Scholar 

  13. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg. 1986;44:708–13.

    Article  CAS  PubMed  Google Scholar 

  14. Yanagisawa M, Kakizaki H, Okada K, Torigoe T, Kusumi T. p63 as a prognostic marker for giant cell tumor of bone. Upsala J Med Sci. 2013;118:23–8.

    Article  PubMed  Google Scholar 

  15. Shooshtarizadeh T, Rahimi M, Movahedinia S. p63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions. Pathol Res Pract. 2016;212(10):876–9.

    Article  CAS  Google Scholar 

  16. Wülling M, Delling G, Kaiser E. The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum Pathol. 2003;34(10):983–93.

    Article  Google Scholar 

  17. Lau CP, Ng PK, Li MS, Tsui SK, Huang L, Kumta SM. p63 regulates cell proliferation and cell cycle progression-associated genes in stromal cells of giant cell tumor of the bone. Int J Oncol. 2013;42(2):437–43.

    Article  CAS  Google Scholar 

  18. Lee CH, Espinosa I, Jensen KC. Gene expression profiling identified p63 as a diagnostic marker for giant cell tumor of the bone. Mod Pathol. 2008;21:531–9.

    Article  CAS  Google Scholar 

  19. Forsyth RG, Boeck G, Bekaert S. Telomere biology in giant cell tumour of bone. J Pathol. 2008;214:555–63.

    Article  CAS  Google Scholar 

  20. Kim Y, Nizami S, Goto H, Lee FY. Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor. Clin Orthop Surg. 2012;4(2):107–16.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Vasconcelos RG, Vasconcelos MG, Queiroz LM. Peripheral and central giant cell lesions: etiology, origin of giant cells, diagnosis and treatment. J Braz Pathol Med Lab. 2013;49(6):446–52.

    Google Scholar 

  22. Kahn A, Chaushu G, Ginene L, Vered M. Age and expression of CD163 and colony-stimulating factor 1 receptor (CD115) are associated with the biological behavior of central giant cell granuloma. J Oral Maxillofac Surg. 2017;75(7):1414–24.

    Article  PubMed  Google Scholar 

  23. Flanagan AM, Tinkler S, Horton MA, Williams DM, Chambers TJ. The multinucleate cells in giant cell granulomas of the jaw are osteoclasts. Cancer. 1988;62(6):1139–45.

    Article  CAS  PubMed  Google Scholar 

  24. Liu B, Yu SF, Li TJ. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med. 2003;32(6):367–75.

    Article  PubMed  Google Scholar 

  25. Datta HK, Ng WF, Walker JA, Tuck SP, Varanasi SS. The cell biology of bone metabolism. J Clin Pathol. 2008;61(5):577–87.

    Article  CAS  PubMed  Google Scholar 

  26. De Paula AM, Vasiljevic A, Giorgi R, Gomez-Brouchet A, Aubert S, Leroy X. A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry when more than 50% of cells is stained. Virchows Arch. 2014;465(4):487–94.

    Article  Google Scholar 

  27. Reis Filho JS, Torio B, Albergaria A, Schmitt FC. p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol. 2002;29(9):517–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral Pathology & Microbiology, Government Dental College & Hospital, PD’Mello Road, St. George Hospital Campus, Near Chatrapati Shivaji Terminus, Mumbai, Maharashtra, 400001, India

    Saurabh R. Nagar & Anuradha Sinha

  2. Department of Oral & Maxillofacial Pathology, Nair Hospital Dental College, Dr. A.L. Nair Road, Mumbai Central, Mumbai, 400008, India

    Shivani Bansal & Rajiv S. Desai

  3. Department of Pathology, BYL Nair Ch. Hospital & T.N.M.C., Mumbai Central, Mumbai, 400008, India

    Kusum Jashnani

Authors
  1. Saurabh R. Nagar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shivani Bansal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kusum Jashnani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anuradha Sinha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rajiv S. Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shivani Bansal.

Ethics declarations

Conflict of interest

No conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nagar, S.R., Bansal, S., Jashnani, K. et al. A Comparative Analysis of p63 Expression in Giant Cell Tumour (GCT), Central Giant Cell Granuloma (CGCG) and Peripheral Giant Cell Granuloma (PGCG). Head and Neck Pathol 14, 733–741 (2020). https://doi.org/10.1007/s12105-019-01118-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-019-01118-x

Keywords

Search

Navigation